Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Inks Deal With TGen for Skin Cancer Genetics

NEW YORK, Aug. 31 (GenomeWeb News) - Sequenom will provide the Translational Genomics Research Institute access to its candidate gene portfolio of targets associated with and individual's predisposition for skin cancer, the company announced today.

 

Under the terms of the agreement, TGen will further validate the candidate genes against its expression databases with regard to their potential use as diagnostic markers for skin cancer risk and for the clinical prognosis of skin cancer patients. Any products resulting from the collaboration will be jointly owned and commercialized, Sequenom said.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.